Furthermore, Il18−/− mice exhibited higher blood glucose and lipid levels, insulin resistance, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH) with aging. Here, IL18 is linked to metabolic dysfunction-associated steatotic liver disease.